Reviews in Endocrine & Metabolic Disorders

Papers
(The TQCC of Reviews in Endocrine & Metabolic Disorders is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review178
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review148
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality137
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus108
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb89
The genetics of Graves’ disease86
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review83
Diagnostic and prognostic utility of phase angle in patients with cancer72
Traumatic brain injury and prolactin69
Endocrine responses of the stress system to different types of exercise62
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease55
Posttranslational modifications in diabetes: Mechanisms and functions52
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond50
Prolactin deficiency in the context of other pituitary hormone abnormalities43
Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review40
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic39
Preface39
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients38
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis37
Androgens, aging, and prostate health37
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease37
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence36
Appetitive interoception, the hippocampus and western-style diet35
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review34
No longer to be ignored: Hypophosphatemia following intravenous iron administration34
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy34
Mention to Prof. Andrew V. Schally33
Hypothalamic GHRH33
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries32
Deep neural network for food image classification and nutrient identification: A systematic review32
Correction: Hypothalamic GHRH32
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome31
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations30
Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes30
Towards precision medicine in non-alcoholic fatty liver disease30
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities29
Novel treatments for congenital adrenal hyperplasia29
Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing’s syndrome: A systematic review and meta-analysis28
Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis28
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and COVID-19 infection27
Regulation of adipogenesis by exosomal milk miRNA27
Rathke’s cleft cyst: From history to molecular genetics26
Uterine fibroids in women diagnosed with acromegaly: a systematic review26
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review26
Computational approaches to predicting treatment response to obesity using neuroimaging26
Vitamin D, infections and immunity25
GHRH in diabetes and metabolism25
Food cue reactivity: Neurobiological and behavioral underpinnings25
Correction to: Chemotherapy in NEN: still has a role?25
Hypoprolactinemia, a neglected endocrine disorder25
Molecular testing for thyroid nodules: Where are we now?25
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies24
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences24
ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity24
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients24
Prolactin: structure, receptors, and functions23
Fluorescence-guided detection of pituitary neuroendocrine tumor (PitNET) tissue during endoscopic transsphenoidal surgery available agents, their potential, and technical aspects23
Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment – A Review22
Endogenous Cushing’s syndrome during pregnancy22
Phase angle in applications of bioimpedance in health and disease21
Gut-brain mechanisms underlying changes in disordered eating behaviour after bariatric surgery: a review21
The emerging role of transcription factor FOXP3 in thyroid cancer21
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity21
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group20
Continuous glucose monitoring in patients with inherited metabolic disorders at risk for Hypoglycemia and Nutritional implications20
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management20
Reference intervals for serum prolactin concentrations: analytical and clinical considerations20
Phase angle as an index of physiological status: validating bioelectrical assessments of hydration and cell mass in health and disease20
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions20
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities20
Phase angle in localized bioimpedance measurements to assess and monitor muscle injury20
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes19
A systematic review of resting-state functional connectivity in obesity: Refining current neurobiological frameworks and methodological considerations moving forward19
Phase angle and COVID-19: A systematic review with meta-analysis19
Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management18
Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis18
Surgical outcomes of partial adrenalectomy for pheochromocytoma: A systematic review and meta-analysis18
Contribution of the microbiome for better phenotyping of people living with obesity18
0.041504144668579